where is semaglutide sourced from A $60 billion industry just found its next growth lever. 💊 With the expiry of a key patent on March 20, 2026, Indian pharma majors are launching generic weight-loss and diabetes drugs When it comes to GLP-1

So theres something for all fitness levels

"Weight loss is already part of the recommendations for many patients with arthritis, but our study may indicate that medication such as Wegovy could have a dual effect -- both through weight loss and by increasing GLP-1 levels in the joints," Kragstrup said

Os desfechos relatados incluem marcadores de atividade osteoblstica, ndices de formao ssea e medidas relacionadas ao balano de nitrognio em condies laboratoriais controladas [2] , [3] , [4]

Funding: The authors received no financial support for the research, authorship, and/or publication of this article

A: People who dislike needles, prefer simpler routines, travel frequently, or struggled with injectable adherence may prefer the pill format